Articles by : Shannon Young, Associate Editor/Senior Writer

In Stinging Op-Ed, West Virginia Senate Leader Bashes Drug Industry and Rejects Efforts to Politicize 340B Program

June 13, 2024 Shannon Young, Associate Editor/Senior Writer Views

West Virginia Senate President Craig Blair (R), who also serves as the state’s lieutenant governor, told 340B Report that he’s weighing potential litigation against Stand for Us PAC, which has claimed credit for the GOP leader’s May 14 primary loss. (Photo courtesy: WV Senate.)

A key West Virginia lawmaker this week hit back against efforts to tie the 340B program to partisan politics, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Supreme Court to Review Case that Could Result in More Hospitals Qualifying for 340B Program

June 13, 2024 Shannon Young, Associate Editor/Senior Writer Views

Supreme Court Justices announced in a June 10 order that they’d review the U.S. Court of Appeals for the D.C. Circuit’s September 2023 decision in Advocate Christ Medical Center v. Becerra.

The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bausch & Lomb Becomes 35th Manufacturer to Impose Contract Pharmacy Restrictions, Policy Applies to All 340B Entities

June 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

Canadian drug manufacturer Bausch & Lomb announced contract pharmacy restrictions that apply to all 340B covered entity types.

Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Mount Sinai Reports 340B Pharmacy Revenue Losses in Early 2024

June 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

New York City-based Mount Sinai Hospital reported significantly decreased 340B pharmacy revenue at the start of 2024.

A major New York City hospital reported that decreased 340B pharmacy revenue helped drive millions in year-over-year losses in one [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say

June 6, 2024 Shannon Young, Associate Editor/Senior Writer Views

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sobi Becomes 34th Drugmaker to Implement Contract Pharmacy Restrictions, Exelixis Tightens Contract Pharmacy Policy

June 6, 2024 Shannon Young, Associate Editor/Senior Writer Views

California-based Exelixis, a specialty manufacturer with two high-priced drug products on the market, announced it is further restricting contract pharmacy access to 340B hospitals in a May 31 letter published on 340B ESP.

Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

OPA to Hold June 11 Webinar on Final ADR Rule

June 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.

The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

RWC-340B Slams ASAP 340B Bill as ‘Dangerous to Public Health’

May 31, 2024 Shannon Young, Associate Editor/Senior Writer Views

Shannon Burger, president of RWC-340B,, said the organization “strongly opposes" a new 340B overhaul bill.

A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

ASAP 340B-Backed Bill Would Override State Laws, Could Hurt Contract Pharmacy Agreements, Critics Warn

May 31, 2024 Shannon Young, Associate Editor/Senior Writer Views

Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.

Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Key House Oversight Subcommittee to Hold Hearing on 340B Next Tuesday

May 29, 2024 Shannon Young, Associate Editor/Senior Writer Views

Rep. Cathy McMorris Rogers (R-Washington) chair of the Energy & Commerce Committee, and Rep. Morgan Griffith (R-Virginia), chair of the Oversight and Investigations Subcommittee, announced a June 4 hearing on 340B.

A subcommittee of the House Energy and Commerce (E&C) Committee, which is tasked with overseeing the 340B drug discount program, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live